Clinical Research Directory
Browse clinical research sites, groups, and studies.
Development of a Pan-Cancer Screening Model Based on Blood Biomarkers
Sponsor: Zhejiang Cancer Hospital
Summary
This study aims to develop a pan-cancer screening model using routine blood biomarkers (including complete blood count, biochemical tests, coagulation panel, and tumor markers). The study is retrospective, collecting data from approximately 10,000,000 cancer patients diagnosed at multiple centers in China between January 2006 and September 2025. All patients have confirmed pathological diagnosis and complete blood test records. A Mixture of Experts (MoE) machine learning model will be built to predict the presence of various cancers (e.g., gastric, colorectal, liver, lung, ovarian cancer). The goal is to establish a low-cost, non-invasive screening tool suitable for large-scale population screening.
Official title: Establishment of a Pan-Cancer Screening Model Based on Blood Biomarkers
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
10000000
Start Date
2025-10-22
Completion Date
2030-12-31
Last Updated
2026-04-28
Healthy Volunteers
Yes
Conditions
Interventions
No intervention
This is an observational, retrospective study with no assigned interventions. Data are collected from existing medical records, including routine blood biomarkers (complete blood count, biochemistry, coagulation panel, tumor markers). No experimental drugs, devices, or procedures are administered. Only de-identified historical data are used for model development.
Locations (1)
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China